454 related articles for article (PubMed ID: 32349998)
1. Antifungal Susceptibility Testing: Current Approaches.
Berkow EL; Lockhart SR; Ostrosky-Zeichner L
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349998
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
Cuenca-Estrella M; Rodriguez-Tudela JL
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
[TBL] [Abstract][Full Text] [Related]
4. Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex.
Salsé M; Gangneux JP; Cassaing S; Delhaes L; Fekkar A; Dupont D; Botterel F; Costa D; Bourgeois N; Bouteille B; Houzé S; Dannaoui E; Guegan H; Charpentier E; Persat F; Favennec L; Lachaud L; Sasso M
Clin Microbiol Infect; 2019 Dec; 25(12):1546-1552. PubMed ID: 31082487
[TBL] [Abstract][Full Text] [Related]
5. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.
Espinel-Ingroff A; Turnidge J
Rev Iberoam Micol; 2016; 33(2):63-75. PubMed ID: 27296911
[TBL] [Abstract][Full Text] [Related]
6. The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus.
Ostrosky-Zeichner L; Andes D
J Infect Dis; 2017 Aug; 216(suppl_3):S452-S457. PubMed ID: 28911047
[TBL] [Abstract][Full Text] [Related]
7. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
[TBL] [Abstract][Full Text] [Related]
8. The future of fungal susceptibility testing.
Posteraro B; Sanguinetti M
Future Microbiol; 2014; 9(8):947-67. PubMed ID: 25302953
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey.
Rambach G; Oberhauser H; Speth C; Lass-Flörl C
Med Mycol; 2011 Nov; 49(8):856-63. PubMed ID: 21619497
[TBL] [Abstract][Full Text] [Related]
10. Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus.
Meletiadis J; Leth Mortensen K; Verweij PE; Mouton JW; Arendrup MC
Clin Microbiol Infect; 2017 Feb; 23(2):98-103. PubMed ID: 27793736
[TBL] [Abstract][Full Text] [Related]
11. EUCAST technical note on Amphotericin B.
Lass-Flörl C; Arendrup MC; Rodriguez-Tudela JL; Cuenca-Estrella M; Donnelly P; Hope W;
Clin Microbiol Infect; 2011 Dec; 17(12):E27-9. PubMed ID: 22011310
[TBL] [Abstract][Full Text] [Related]
12. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Idelevich EA; Groß U; Becker K; Bader O
Diagn Microbiol Infect Dis; 2018 May; 91(1):52-54. PubMed ID: 29422272
[TBL] [Abstract][Full Text] [Related]
14. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
[TBL] [Abstract][Full Text] [Related]
15. Current status of antifungal susceptibility testing methods.
Arikan S
Med Mycol; 2007 Nov; 45(7):569-87. PubMed ID: 17885947
[TBL] [Abstract][Full Text] [Related]
16. Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.
Buil JB; van der Lee HAL; Rijs AJMM; Zoll J; Hovestadt JAMF; Melchers WJG; Verweij PE
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923874
[TBL] [Abstract][Full Text] [Related]
17. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
18. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
[TBL] [Abstract][Full Text] [Related]
19. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
